Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.80837 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.61901 | 61 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.67617 | 62 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.46614 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.59256 | 61 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.86567 | 63 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.08505 | 67 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.78099 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.65883 | 61 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.63241 | 61 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.75378 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.66672 | 62 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.36125 | 54 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.6863 | 62 |